Octreotide Acetate has passed the evaluation of Chinese NMPA!
Another API of Hybio Wuhan site, Octreotide Acetate, has passed the evaluation of Chinese NMPA! This API can be used in FDF commercial production for marketing.
Great work for our Wuhan team! For their unremitting efforts since the operation of the site in 2019! We look forward to have more approvals soon.
© 2021 Hybio Pharma. All Rights Reserved.
Peptide Products & Services
About us
Newsroom
Follow us